Search
Search Results
-
Afterdischarges in myotonic dystrophy type 1
ObjectiveElectrodiagnostic testing is an important screening test for myotonic dystrophy type 1 (DM1). Although myotonic discharges are observed on...
-
Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2
BackgroundMyotonic dystrophy is a multisystem disorder characterized by widespread organic involvement including central nervous system symptoms....
-
Myotonic dystrophy type 1 in the COVID-19 era
IntroductionMyotonic dystrophy type 1 (DM1) is the most prevalent muscular dystrophy in adults. People with DM1 might represent a high-risk...
-
Update on Therapy for Myotonic Dystrophy Type 1
Purpose of reviewThis review aimed to summarize the clinical characteristics of myotonic dystrophy type 1 and to provide a comprehensive review of...
-
Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1
BackgroundAs the most common subtype of adult muscular dystrophy worldwide, large cohort reports on myotonic dystrophy type I (DM1) in China are...
-
Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2
Myotonic dystrophy type 2 (DM2) is an autosomal-dominant multisystemic disease with a core manifestation of proximal muscle weakness, muscle atrophy,...
-
Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles
BackgroundSeverity and nature of cognitive impairments in Myotonic dystrophy type 1 (DM1) are heterogeneous among studies. We hypothesized that this...
-
Ocular findings in a Spanish cohort of myotonic dystrophy type 1
PurposeMyotonic dystrophy type 1 is the most common muscular dystrophy in adulthood, caused by a triplet repeat in chromosome 19q13.3. The present...
-
Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks
Background and purposeMyotonic dystrophy type 1 (DM1) is an inherited neuromuscular disorder characterized by myotonia and progressive muscle...
-
Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1
BackgroundAlthough functional impairment in patients with myotonic dystrophy is an important determinant of the quality of life (QoL), patients’...
-
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1
Background and purposeMyotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy and is caused by an repeat expansion...
-
Clinical score for early diagnosis of myotonic dystrophy type 2
IntroductionMyotonic dystrophy type 2 (DM2) is a rare, multisystemic, autosomal dominant disease with highly variable clinical presentation. DM2 is...
-
Nationwide incidence of myotonic dystrophy type 1 and the status of multi-organ involvement
PurposeThis study aimed to investigate the incidence of myotonic dystrophy type 1 (DM1) and the status of multi-organ involvement.
Methods ...
-
Current Treatment Options for Patients with Myotonic Dystrophy Type 2
Purpose of the reviewMyotonic dystrophy types 1 and 2 are frequent forms of muscular dystrophies in adulthood. Their clinical differences need to be...
-
Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study
AimMuscular dystrophy (MD) is a progressive disease with predominantly muscular symptoms. Myotonic dystrophy type II (MD2) and facioscapulohumeral...
-
Development of prediction models based on respiratory assessments to determine the need for non-invasive ventilation in patients with myotonic dystrophy type 1
IntroductionMyotonic dystrophy type 1 is a slowly progressive, multisystem, autosomal dominant disorder, in which the impairments of respiratory...
-
Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death
ObjectivesThe mechanism and pathological substrate of arrhythmogenic events in dystrophic myopathy type 1 (DM1) have not been fully established,...
